Abstract The 2021 WHO Classification of Thoracic Tumours was published earlier this year,
with classification of lung tumors being one of the chapters. The principles remain those of …

Lung cancer remains the most common cause of cancer death in the United States of
America and worldwide despite continued advances in lung cancer screening as well as …

Background Recent research has shown that immune-related lncRNA plays a crucial part in
the tumor immune microenvironment. This study tried to identify immune-related lncRNAs …

Stage III nonsmall cell lung cancer (NSCLC) comprises about one-third of NSCLC patients
and is very heterogeneous with varying and mostly poor prognosis. It is also called …

Objectives Ki-67 is a key molecular marker to indicate the proliferative activity of tumor cells
in lung cancer. However, Ki-67 expression and its prognostic significance in histological …

Objective: To evaluate the value of the non-predominant micropapillary and solid patterns in
prognosis of lung adenocarcinoma. Methods: Totally 422 patients diagnosed with stage IA …

Background We investigated the clinical features and surgical outcomes of lung
adenocarcinoma with minimal solid or micropapillary (S/MP) components, with a focus on …

Introduction Recent lung adenocarcinoma (LUAD) grading system proposed by the
International Association for the Study of Lung Cancer (IASLC) has emphasized the …

Advancements in the classification of lung adenocarcinoma have resulted in significant
changes in pathological reporting. The eighth edition of the tumour–node–metastasis (TNM) …

Background: Limited resection has gradually become an acceptable treatment for lung
adenocarcinomas (ADCs) presenting as ground-glass nodules (GGNs). However, its role in …